Johnson & Johnson (JNJ) insider buying

Healthcare · Drug Manufacturers - General · Market cap $632.9B

21 open-market purchases of JNJ by Johnson & Johnson's executives and directors since October 2025, worth $0 in total, from SEC Form 4 filings.

The most recent: Lloyd Doggett bought — on March 10, 2026.

The biggest buyer over the period is Lloyd Doggett: 6 purchases, $0.

By year

YearPurchasesValue
20266$0
202515$0

Biggest buyers

InsiderBuysValue
Lloyd Doggett
6$0
Ro Khanna
9$0
Richard Mccormick
3$0
Lisa C. Mcclain
3$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 10, 2026 Lloyd Doggett
0$243.75— —
Mar 10, 2026 Lloyd Doggett
0$243.75— —
Mar 10, 2026 Lloyd Doggett
0$243.75— —
Feb 5, 2026 Ro Khanna
0$237.66— —
Feb 5, 2026 Ro Khanna
0$237.66— —
Feb 5, 2026 Ro Khanna
0$237.66— —
Dec 9, 2025 Lloyd Doggett
0$199.99— —
Dec 9, 2025 Lloyd Doggett
0$199.99— —
Dec 9, 2025 Lloyd Doggett
0$199.99— —
Nov 7, 2025 Ro Khanna
0$186.50— —
Nov 7, 2025 Ro Khanna
0$186.50— —
Nov 7, 2025 Ro Khanna
0$186.50— —
Nov 5, 2025 Richard Mccormick
0$186.23— —
Nov 5, 2025 Richard Mccormick
0$186.23— —
Nov 5, 2025 Richard Mccormick
0$186.23— —
Oct 30, 2025 Lisa C. Mcclain
0$189.05— —
Oct 30, 2025 Ro Khanna
0$189.05— —
Oct 30, 2025 Lisa C. Mcclain
0$189.05— —
Oct 30, 2025 Ro Khanna
0$189.05— —
Oct 30, 2025 Ro Khanna
0$189.05— —
Oct 30, 2025 Lisa C. Mcclain
0$189.05— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for JNJ.
Open JNJ in Investingly

Questions

Are Johnson & Johnson insiders buying the stock?

21 open-market purchases of JNJ by Johnson & Johnson's executives and directors since October 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Lloyd Doggett bought — on March 10, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Johnson & Johnson's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.